Real-World Perspectives on Switching Patients With Multiple Sclerosis From Anti-CD20 Therapy to Cladribine Tablets From US-Based Advanced Practice Providers: A Podcast

<p dir="ltr"><b>Article full text</b> The above Podcast represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, and copyright information, please see the full text online (see “read the peer-reviewed publication” opposite).</p>